Market Capitalization Изменить Дата
AbbVie USD 313.64B 40.03B 2024-03
Agios Pharmaceuticals USD 1.68B 434M 2024-03
Alnylam Pharmaceuticals USD 18.47B 5.56B 2024-03
Amgen USD 148.35B 5.79B 2024-03
Arrowhead Research USD 3.37B 84M 2024-03
Astellas Pharma JPY 3.04T 709.27B 2023-12
AstraZeneca GBP 164.29B 7.78B 2023-12
Bayer EUR 44.65B 4.92B 2023-09
Biogen USD 31.4B 6.09B 2024-03
BioMarin Pharmaceutical USD 15.87B 2.29B 2024-03
Bluebird Bio USD 325M 25M 2023-09
Bristol-Myers Squibb USD 105.66B 1.26B 2024-03
Daiichi Sankyo JPY 7.52T 473.2B 2023-12
Eli Lilly USD 731.69B 178.32B 2024-03
Exelixis USD 7.26B 205M 2024-03
Gilead Sciences USD 90.93B 10.01B 2024-03
GlaxoSmithKline GBP 59.68B 1.42B 2023-12
Incyte USD 12.89B 1.18B 2024-03
Ionis Pharmaceuticals USD 6.19B 1.07B 2024-03
Merck USD 314.33B 38.07B 2024-03
Moderna USD 40.08B 2.16B 2024-03
Nektar Therapeutics USD 113M 4M 2023-09
Novartis CHF 193.29B 20.5B 2023-12
Pfizer USD 155.51B 7.05B 2024-03
Regeneron Pharmaceuticals USD 106.74B 11.05B 2024-03
Roche Holding CHF 199.67B 23.81B 2023-12
Sarepta Therapeutics USD 11.76B 2.73B 2024-03
Vertex Pharmaceuticals USD 106.53B 1.68B 2024-03



Agios Pharmaceuticals Рыночная Капитализация - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2024.